Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 182.01 -1.62 (0.88%)
Previous Close $183.63    52 Week High $160.00 
Open $179.68    52 Week Low $95.80 
Day High $183.45    P/E 33.83 
Day Low $176.67    EPS $5.38 
Volume 982,771